![](/images/graphics-bg.png)
Cystatin C is an early marker of contrast-induced nephropathy in patients with sepsis in the intensive care
المؤلف
المصدر
Saudi Journal of Kidney Diseases and Transplantation
العدد
المجلد 26، العدد 4 (31 أغسطس/آب 2015)، ص ص. 718-724، 7ص.
الناشر
تاريخ النشر
2015-08-31
دولة النشر
السعودية
عدد الصفحات
7
التخصصات الرئيسية
الموضوعات
الملخص EN
Contrast-induced nephropathy (CIN) is becoming an increasingly common cause of acute kidney injury in hospitalized patients.
To evaluate the prevalence of CIN in critically ill patients, we conducted a prospective study on intensive care unit patients who had undergone diagnostic computed tomography scan or non-coronary angiography with intravenous administration of iodinated contrast media.
Patient demographics, disease characteristics and biochemical markers, including cystatin C, creatinine and urea, were compared between the patients who developed and those who did not develop CIN.
A total of 42 patients were diagnosed with sepsis, 52 were diagnosed with diabetes mellitus, 18 with ischemic heart disease and 49 with hypertension.
We found a similar incidence of CIN among the groups (28.6–36.8%).
There was no association of patient age, gender or body mass index with the development of CIN.
In sepsis patients, cystatin C levels were significantly raised at baseline in patients who developed CIN (P = 0.020) and also on the day before CIN was detected (P = 0.035) and the day of CIN detection (P = 0.012).
No associations with cystatin C or other serum or urinary biomarkers were detected in any of the other disease groups.
In conclusion, a relatively high prevalence of CIN was found in all disease groups.
No demographic or disease factors were found to be associated with the development of CIN.
Cystatin C may be a useful early marker of CIN in sepsis patients, but further work is required to understand the difference in cystatin C expression levels in patients with different underlying pathologies.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
al-Baladi, Fatimah I.. 2015. Cystatin C is an early marker of contrast-induced nephropathy in patients with sepsis in the intensive care. Saudi Journal of Kidney Diseases and Transplantation،Vol. 26, no. 4, pp.718-724.
https://search.emarefa.net/detail/BIM-592714
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
al-Baladi, Fatimah I.. Cystatin C is an early marker of contrast-induced nephropathy in patients with sepsis in the intensive care. Saudi Journal of Kidney Diseases and Transplantation Vol. 26, no. 4 (Jul. / Aug. 2015), pp.718-724.
https://search.emarefa.net/detail/BIM-592714
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
al-Baladi, Fatimah I.. Cystatin C is an early marker of contrast-induced nephropathy in patients with sepsis in the intensive care. Saudi Journal of Kidney Diseases and Transplantation. 2015. Vol. 26, no. 4, pp.718-724.
https://search.emarefa.net/detail/BIM-592714
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 724
رقم السجل
BIM-592714
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)